PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Total Receivables
$187.2m
CAGR 3-Years
33%
CAGR 5-Years
19%
CAGR 10-Years
71%
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.7B
CAGR 3-Years
6%
CAGR 5-Years
16%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$6.9B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.7B
CAGR 3-Years
21%
CAGR 5-Years
29%
CAGR 10-Years
35%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$5.7B
CAGR 3-Years
-7%
CAGR 5-Years
18%
CAGR 10-Years
20%

See Also

What is PTC Therapeutics Inc's Total Receivables?
Total Receivables
187.2m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Total Receivables amounts to 187.2m USD.

What is PTC Therapeutics Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
71%

Over the last year, the Total Receivables growth was 5%. The average annual Total Receivables growth rates for PTC Therapeutics Inc have been 33% over the past three years , 19% over the past five years , and 71% over the past ten years .

Back to Top